Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

Cancer a life-threatening disease can spread or metastasise from its original location to other parts of the body The lungs ...

As with the Philadelphia Eagles at half time of Super Bowl LIX, a team of ASX biotechs is not quite over the line but has the ...

AIIMS to launch a neurotechnology facility with the Vattikuti Foundation, featuring non-invasive MRgFUS treatment for ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

New research suggests that cancer survivors experiencing pain are more likely to use cannabis and cigarettes but less likely to consume alcohol.

After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

Experiencing pain may increase the odds that cancer survivors will use cigarettes and cannabis, according to a recent study published by Wiley online in CANCER, a peer-reviewed journal of the American ...

Therefore, the analyses were limited to 4130 adults who self-reported a history of cancer. The most common cancer types reported included prostate ... prevalence of pain in patients with cancer ...

The Elekta Unity MR-LINAC system, used at Allegheny General Hospital, combines MRI imaging with radiation therapy to target cancerous cells with pinpoint precision.

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

7, 2025 — Pancreatic cancer patients may benefit from future precision ... Alarming Rise in Rates of Advanced Prostate Cancer in California Feb. 3, 2025 — The incidence of advanced prostate ...